Prices are updated after-hours

N::A 2022 - 11 - 18

TPCO Holding Corp.

GRAMF 4 | $0.1587 10.27% 86K

(0.0% 1d) (0.0% 1m) (-15.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (60.26% volume)
Earnings Calendar:
Market Cap: $ 19,054,397

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Parsec Capital Acquisitions Corp.

PCX | $10.2 4.9%

n/a

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-94.63% volume)
Earnings Calendar:
Market Cap:

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Focus Impact Acquisition Corp.

FIAC | $11.04 0.09% 8.6K

n/a

(0.0% 1d) (0.2% 1m) (6.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.33% volume)
Earnings Calendar:
Market Cap: $ 74,162,061
https://focus-impact.com
Sec Filling | Patents | 2021 employees

we have formed focus impact acquisiton corporation, a blank check company targeting investing in a high growth company that is meaningfully aligned with one or more of four un sdgs: good health and well-being, quality education, decent work and economic growth and reduced inequality.

education

add to watch list Paper trade email alert is off

Future Health ESG Corp.

FHLT S | $12.5 0.0% 21K

n/a

(0.0% 1d) (12.3% 1m) (28.5% 1y) (5.8% 2d) (-0.3% 3d) (0.0% 7d) (-98.07% volume)
Earnings Calendar:
Market Cap: $ 74,205,588
https://fhesg.com
Sec Filling | Patents | 2021 employees

$200m spac led by healthcare technology industry experts focused on disruptive health-tech companies that leverage data science to improve and personalize healthcare.

spac

add to watch list Paper trade email alert is off

Apeiron Capital Investment Corp.

APN | $10.37 0.19% 0.0% 120

n/a

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-83.68% volume)
Earnings Calendar:
Market Cap: $ 178,882,500

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

BitNile Holdings, Inc.

NILE 4 | $0.1225 0.0%

n/a

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (104.08% volume)
Earnings Calendar:
Market Cap: $ 41,658,502
https://www.aultglobal.com
Sec Filling | Patents | 154 employees

(US) Ault Global Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly and majority-owned subsidiaries and strategic investments, the Company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, and textiles. In addition, the Company extends credit to select entrepreneurial businesses through a licensed lending subsidiary. The Company's headquarters are located at 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141

defense

add to watch list Paper trade email alert is off

Gardiner Healthcare Acquisitions Corp.

GDNR | $10.9 0.0% 31K

n/a

(0.0% 1d) (0.0% 1m) (3.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-75.35% volume)
Earnings Calendar:
Market Cap: $ 40,972,010

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Just Eat Takeaway.com N.V.

TKAYF | $15.35 3.79% 220

n/a

(0.0% 1d) (-6.3% 1m) (-9.7% 1y) (0.0% 2d) (-6.3% 3d) (0.0% 7d) (10.0% volume)
Earnings Calendar:
Market Cap: $ 3,376,479,006
http://corporate.takeaway.com
Sec Filling | Patents | n/a employees

(NL) Just Eat Takeaway.com NV owns and manages food delivery websites. The company connects consumers and restaurants through its platform in European countries and Israel. It offers consumers a wide variety of food choice. The company was founded by Jitse Groen in 2000 and is headquartered in Amsterdam, the Netherlands.

israel

add to watch list Paper trade email alert is off

Hammerhead Energy Inc.

HHRS | $15.32 0.46% 1.1K

n/a

(0.0% 1d) (0.0% 1m) (80.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.48% volume)
Earnings Calendar:
Market Cap: $ 1,395,291,674

Sec Filling | Patents | 2 employees

add to watch list Paper trade email alert is off

Virax Biolabs Group Ltd

VRAX | $0.644 -5.25% -5.54% 8.2K

n/a

(0.0% 1d) (-14.3% 1m) (58.1% 1y) (0.0% 2d) (-1.4% 3d) (0.7% 7d) (-78.41% volume)
Earnings Calendar:
Market Cap: $ 10,012,325

Sec Filling | Patents | 2022 employees

add to watch list Paper trade email alert is off

Alvotech Lux Holdings S.A.S.

ALVO | News | $13.23 2.64% 2.57% 1.7M

n/a

(0.0% 1d) (-16.4% 1m) (27.9% 1y) (0.0% 2d) (0.0% 3d) (1.8% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 3,530,052,996

Sec Filling | Patents | 917 employees

alvotech was founded in 2013, with the clear mission to become a global leader in biogenerics, defined as differentiated, high-quality, cost-controlled biosimilars. we have pursued this goal by creating a fully-integrated specialty company in control of every value adding development step from cell line development to commercial manufacturing of the product. our in-house development and manufacturing platform located at four sites across europe drives timely development of a strong and differentiated portfolio, while our state-of-the-art flexible manufacturing facility, located in reykjavik iceland, ensures high quality and cost-effective production. we are passionate about what we have created and our stated purpose of transforming access to life-altering therapies for patients across the globe. we believe in focus and specialization and each of our 250 professionals share our passion and pride to be part of this mission. we are dedicated to making people's lives better by improving a

t-cell

add to watch list Paper trade email alert is off

NewAmsterdam Pharma Co B.V.

NAMS | $19.98 2.78% 2.7% 140K

n/a

(0.0% 1d) (-9.4% 1m) (27.8% 1y) (0.0% 2d) (0.0% 3d) (1.6% 7d) (-91.52% volume)
Earnings Calendar:
Market Cap: $ 1,783,548,127

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Trio Petroleum Corp.

TPET | $0.3975 21.23% -2.19% 50M

n/a

(0.0% 1d) (223.8% 1m) (-84.7% 1y) (0.0% 2d) (0.0% 3d) (-46.0% 7d) (-23.45% volume)
Earnings Calendar:
Market Cap: $ 14,672,450

Sec Filling | Patents | 3 employees

add to watch list Paper trade email alert is off

Onfolio Holdings, Inc

ONFO | $0.4375 -4.87% -5.12% 59K

n/a

(0.0% 1d) (-29.1% 1m) (-70.2% 1y) (0.0% 2d) (0.0% 3d) (-2.7% 7d) (-70.06% volume)
Earnings Calendar:
Market Cap: $ 2,234,485
https://www.pharming.com/
Sec Filling | Patents | 889 employees

pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. pharming’s lead product, ruconest® (conestat alfa) is a recombinant human c1 esterase inhibitor approved for the treatment of acute hereditary angioedema (“hae”) attacks in patients in europe, the us, israel and south korea. the product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization. ruconest® is commercialized by pharming in austria, france, germany, the netherlands, the united kingdom, and the united states of america. pharming’s technology platform includes a unique, gmp-compliant, validated process for the production of pure recombinant human proteins that has proven capable of producing industrial quantities of high quality recombinant human proteins in a more economical and less immunogenetic way compared with current cell-line based methods. leads for enzyme repl

t-cell

add to watch list Paper trade email alert is off

D-Wave Quantum Inc.

QBTS | $1.59 -4.79% 0.0% 2.9M

n/a

(0.0% 1d) (-18.5% 1m) (175.0% 1y) (0.0% 2d) (0.0% 3d) (5.7% 7d) (-13.58% volume)
Earnings Calendar:
Market Cap: $ 185,689,301

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Westrock Coffee Holdings, LLC

WEST | $10.22 1.69% 1.66% 110K

n/a

(0.0% 1d) (-0.1% 1m) (-19.0% 1y) (0.0% 2d) (0.0% 3d) (0.7% 7d) (96.01% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 899,706,632
http://www.westrockcoffee.com/
Sec Filling | Patents | 1327 employees

(US) our company's foundational belief is that the free market system of open, competitive trade is the only system that offers sustainable economic hope—along with personal dignity—to those most deeply mired in poverty. for us, sustainability is not a relegated program or detached department. it is our end goal. high-quality, carefully crafted coffee is our opportunity to make real change. coffee has provided us a chance to reimagine the playing field and build a stable, direct channel between farming communities and the end consumer. our team of quality experts, quality graders and coffee cuppers work with our roasters to create roast calculations that are unique to each varietal. they are working every day to develop unique blends and ensure consistency in every cup. we are headquartered in little rock, arkansas where we provide office coffee services to central and northwest arkansas. find our coffee at kroger, harps, bi-lo, winn-dixie, food lion and hannaford or online at www.westrockc

add to watch list Paper trade email alert is off

Spring Valley Acquisition Corp. II

SVII | $11.02 -0.05% -0.05% 5.4K

n/a

(0.0% 1d) (0.5% 1m) (5.9% 1y) (0.0% 2d) (0.0% 3d) (0.1% 7d) (-98.51% volume)
Earnings Calendar:
Market Cap: $ 245,794,841
https://www.verygoodbutchers.com/
Sec Filling | Patents | 1085 employees

we are an emerging plant-based food technology company that designs, develops, produces, distributes and sells a variety of plant-based meat and other food alternatives. our mission is to employ plant-based food technology to create products that are delicious while maintaining a wholesome nutritional profile.

profitable

add to watch list Paper trade email alert is off

BIONOMICS LIMITED/FI

BNOX | $0.98 -1.17% 14K

n/a

(0.0% 1d) (-7.6% 1m) (-59.3% 1y) (0.0% 2d) (0.0% 3d) (-1.7% 7d) (-25.87% volume)
Earnings Calendar:
Market Cap: $ 7,996,448
http://www.bionomics.com.au
Sec Filling | Patents | 2022 employees

(AU) bionomics is a biopharmaceutical company dedicated to making better treatments for cancer, central nervous system disorders such as anxiety, depression and alzheimer's disease. our exceptionally talented team is driven by a shared commitment to make a difference in diseases with inadequate treatment options. we are in a strong growth phase with our world-class portfolio of promising drug candidates from early to advanced stages of clinical development. this portfolio is fed by highly productive drug discovery platforms which includes multicore®, our proprietary chemistry capability. at the core of our business is strategic partnering. we partner with large pharmaceutical companies to get our drugs through the later stages of development and into the market as rapidly as possible. this means we can focus our strengths in innovative drug discovery to extract as many "shots on goal" from our diverse pipeline in the quest to create the world's new blockbuster drugs. we have a passion for

add to watch list Paper trade email alert is off

BELITE BIO, INC

BLTE | $33.49 -3.21% -3.31% 21K

n/a

(0.0% 1d) (-18.7% 1m) (20.2% 1y) (0.0% 2d) (0.0% 3d) (-2.0% 7d) (93.0% volume)
Earnings Calendar:
Market Cap: $ 976,214,880

Sec Filling | Patents | 16 employees

belite bio inc is a san diego based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. developed from our anti-rbp4 technology platform, our lead candidate, lbs-008, is currently in a phase i clinical trial for dry age-related macular degeneration and its juvenile form, stargardt disease. lbs-008 has received orphan drug status in the us and europe, as well as rare pediatric disease status in the us.

add to watch list Paper trade email alert is off

GE Healthcare Holding LLC

GEHC | $84.47 -0.59% -0.59% 1.9M

n/a

(0.0% 1d) (-6.3% 1m) (0.2% 1y) (0.0% 2d) (0.0% 3d) (-2.7% 7d) (-8.39% volume)
Earnings Calendar: 2024-02-06
Market Cap: $ 38,546,048,967

Sec Filling | Patents | 51000 employees

ge healthcare (nyse: ge) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. while we encourage and welcome comments to our linkedin page, these posts from members of the public do not necessarily represent ge healthcare views, and we do not confirm their accuracy or endorse them. ge healthcare is part of highly regulated medical device and pharmaceutical industry. posts and conversations may be removed as a result, but may be forwarded to other people within ge healthcare for follow-up as appropriate. as part of our commitment to you and to the rest of the linkedin members, we will do our best to ensure that the content on the page remains positive. however, since we cannot monitor every post or conversation feed, we realize that the occasional objectionable posts will pop up just from time to time. therefore, the company reserves the right to remove any postings at i

add to watch list Paper trade email alert is off